Journal article
On gene editing and its uses: the views of the public
- Abstract:
-
Rapid advances in genome editing, including CRISPR-Cas9 endonucleases, and their potential application in medicine and enhancement have been hotly debated by scientists and ethicists. Although a veto on germ line gene editing has been proposed1, the use of gene editing on human cells in the clinical context remains controversial, particularly for interventions aimed at enhancement2. In a report on human genome editing the US National Academy of Sciences (NAS) note that “important questions ra...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 81.9KB)
-
- Publisher copy:
- 10.1038/nbt.3958
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Publisher:
- Nature Publishing Group Publisher's website
- Journal:
- Nature Biotechnology Journal website
- Volume:
- 35
- Pages:
- 1021–1023
- Publication date:
- 2017-11-09
- Acceptance date:
- 2017-09-15
- DOI:
- EISSN:
-
1546-1696
- ISSN:
-
1087-0156
- Source identifiers:
-
738331
Item Description
- Pubs id:
-
pubs:738331
- UUID:
-
uuid:1173d669-823d-48d8-9e88-6b2802c72642
- Local pid:
- pubs:738331
- Deposit date:
- 2017-10-24
Terms of use
- Copyright holder:
- Nature Publishing Group
- Copyright date:
- 2017
- Notes:
- © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.This is the accepted manuscript version of the article. The final version is available online from Nature Publishing Group at: http://dx.doi.org/10.1038/nbt.3958
If you are the owner of this record, you can report an update to it here: Report update to this record